1. Chu, DZ, Lang, NP, Thompson, C, et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63:364-367.
Google Scholar | Crossref | Medline2. Verwaal, VJ, van Ruth, S, de Bree, E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743.
Google Scholar | Crossref | Medline3. Verwaal, VJ, Bruin, S, Boot, H, et al. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426-2432.
Google Scholar | Crossref | Medline4. Magge, D, Zenati, MS, Austin, F, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014;21:1159-1165.
Google Scholar | Crossref | Medline5. van Driel, WJ, Koole, SN, Sikorska, K, et al. Hyperthermic Intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378:230-240.
Google Scholar | Crossref | Medline6. Jacquet, P, Averbach, A, Stephens, AD, et al. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: Pharmacokinetic studies. Oncology. 1998;55:130-138.
Google Scholar | Crossref | Medline7. Schmidt, C, Creutzenberg, M, Piso, P, et al. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia. 2008;63:389-395.
Google Scholar | Crossref | Medline8. Miao, N, Pingpank, JF, Alexander, HR, et al. Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: Hemodynamic, metabolic, and anesthetic considerations. Ann Surg Oncol. 2009;16:334-344.
Google Scholar | Crossref | Medline9. Thong, SY, Chia, CS, Ng, O, et al. A review of 111 anaesthetic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Singapore Med J. 2017;58:488-496.
Google Scholar | Crossref | Medline10. Mavroudis, C, Alevizos, L, Stamou, KM, et al. Hemodynamic monitoring during heated intraoperative intraperitoneal chemotherapy using the FloTrac/Vigileo system. Int Surg. 2015;100:1033-1039.
Google Scholar | Crossref | Medline11. Jacquet, P, Sugarbaker, PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359-374.
Google Scholar | Crossref | Medline12. Sugarbaker, PH . Cytoreductive surgery and perioperative intraperitoneal chemotherapy: A new standard of care for appendiceal mucinous tumors with peritoneal dissemination. Clin Colon Rectal Surg. 2005;18(3);204-214.
Google Scholar | Crossref | Medline13. Dindo, D, Demartines, N, Clavien, PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
Google Scholar | Crossref | Medline14. Balakrishnan, KP, Survesan, S. Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective analysis. Indian J Anaesth. 2018;62:188-196.
Google Scholar | Crossref | Medline15. Maciver, AH, Al-Sukhni, E, Esquivel, J, et al. Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: An international survey of high-volume surgeons. Ann Surg Oncol. 2017;24:923-930.
Google Scholar | Crossref | Medline16. Mogal, HD, Levine, EA, Fino, NF, et al. Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: Not always a requirement. Ann Surg Oncol. 2016;23:1486-1495.
Google Scholar | Crossref | Medline17. Balakrishnan, K, Srinivasaraghavan, N, Venketeswaran, MV, et al. Perioperative factors predicting delayed enteral resumption and hospital length of stay in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Retrospective cohort analysis from a single centre in India. Indian J Anaesth. 2020;64(12):1025-1031.
Google Scholar | Crossref | Medline18. White, B, Dahdaleh, F, Naffouje, SA, et al. Impact of enhanced recovery after surgery on postoperative outcomes for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2021;28(9):5265-5272.
Google Scholar | Crossref | Medline19. Osseis, M, Weyrech, J, Gayat, E, et al. Epidural analgesia combined with a comprehensive physiotherapy program after Cytoreductive Surgery and HIPEC is associated with enhanced post-operative recovery and reduces intensive care unit stay: A retrospective study of 124 patients. Eur J Surg Oncol. 2016;42(12):1938-1943.
Google Scholar | Crossref | Medline20. Polanco, PM, Ding, Y, Knox, JM, et al. Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol. 2015;22:1673-1679.
Google Scholar | Crossref | Medline